• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医学疾病中的重度抑郁症:评估、患病率和治疗选择的综述。

Major Depressive Disorder in Medical Illness: A Review of Assessment, Prevalence, and Treatment Options.

机构信息

From the Department of Psychiatry (Thom, Silbersweig, Boland), Brigham and Women's Hospital; and Harvard Medical School (Thom, Silbersweig, Boland), Boston, Massachusetts.

出版信息

Psychosom Med. 2019 Apr;81(3):246-255. doi: 10.1097/PSY.0000000000000678.

DOI:10.1097/PSY.0000000000000678
PMID:30720699
Abstract

Major depression, as well as other depressive disorders, is commonly comorbid with other medical illnesses, particularly chronic and systemic medical illnesses. The co-occurrence of the disorders is so common that it challenges our notions of the meaning of comorbidity and our desire to neatly separate psychiatric and medical illnesses. The overlap between symptoms of physical illness and the neurovegetative symptoms of major depression and the initial normative emotional response to physical illness add to the challenge of accurate diagnosis and timely treatment of depression in the medically ill. We review the literature on the comorbidity of depression and the various medical illnesses, including diagnostic and treatment approaches. The differential diagnosis for major depression among medically ill patients should include delirium and medication-induced symptoms. We suggest that major depression itself may be best conceptualized as a systemic illness whose pathophysiology overlaps with other systemic medical illnesses. The initial treatment strategies for major depression in medical illness are like those for the general population; however, the comorbid medical illnesses may interfere with remission. To illustrate these points, we describe a patient with clinical characteristics covered in this review who experienced major depression as well as several chronic illnesses, including hypersensitivity pneumonitis, multiple sclerosis, chronic pain due to degenerative joint disease, and diabetes mellitus.

摘要

重度抑郁症,以及其他抑郁障碍,通常与其他医学疾病共病,特别是慢性和系统性医学疾病。这些疾病的同时发生非常普遍,这挑战了我们对共病含义的理解,以及我们希望将精神疾病和医学疾病分开的愿望。身体疾病的症状与重度抑郁症的神经植物性症状以及对身体疾病的初始正常情绪反应之间的重叠,增加了准确诊断和及时治疗患有医学疾病的抑郁症的难度。我们回顾了关于抑郁症和各种医学疾病共病的文献,包括诊断和治疗方法。患有医学疾病的重度抑郁症患者的鉴别诊断应包括谵妄和药物引起的症状。我们认为,重度抑郁症本身最好被视为一种全身性疾病,其病理生理学与其他全身性医学疾病重叠。患有医学疾病的重度抑郁症的初始治疗策略与一般人群相同;然而,共病的医学疾病可能会干扰缓解。为了说明这些要点,我们描述了一位具有本综述中涵盖的临床特征的患者,他患有重度抑郁症以及几种慢性疾病,包括过敏性肺炎、多发性硬化症、退行性关节病引起的慢性疼痛和糖尿病。

相似文献

1
Major Depressive Disorder in Medical Illness: A Review of Assessment, Prevalence, and Treatment Options.医学疾病中的重度抑郁症:评估、患病率和治疗选择的综述。
Psychosom Med. 2019 Apr;81(3):246-255. doi: 10.1097/PSY.0000000000000678.
2
[Post-traumatic stress, post-traumatic depression and major depressive episode: literature].创伤后应激障碍、创伤后抑郁与重度抑郁发作:文献综述
Encephale. 2001 Mar-Apr;27(2):159-68.
3
Clinical and health services relationships between major depression, depressive symptoms, and general medical illness.重度抑郁症、抑郁症状与一般躯体疾病之间的临床及健康服务关系。
Biol Psychiatry. 2003 Aug 1;54(3):216-26. doi: 10.1016/s0006-3223(03)00273-7.
4
Improving depression outcomes in older adults with comorbid medical illness.改善患有合并症的老年成年人的抑郁症治疗效果。
Gen Hosp Psychiatry. 2005 Jan-Feb;27(1):4-12. doi: 10.1016/j.genhosppsych.2004.09.004.
5
Major depression and comorbid substance use disorders.重度抑郁症与共病物质使用障碍
Curr Opin Psychiatry. 2008 Jan;21(1):14-8. doi: 10.1097/YCO.0b013e3282f32408.
6
Assessing and managing pain and major depression with medical comorbidities.评估和管理伴有躯体疾病的疼痛和重度抑郁症。
J Clin Psychiatry. 2013 Dec;74(12):e24. doi: 10.4088/JCP.13039vs5c.
7
The co-occurrence of pain and depression in adults with multiple sclerosis.多发性硬化症成年患者中疼痛与抑郁共病现象。
Rehabil Psychol. 2013 May;58(2):217-21. doi: 10.1037/a0032008.
8
Prevalence of substance use and psychiatric disorders in a highly select chronic pain population.高度选择的慢性疼痛人群中物质使用和精神障碍的患病率。
J Addict Med. 2013 Jan-Feb;7(1):17-24. doi: 10.1097/ADM.0b013e3182738655.
9
Depression and medical illness in late life: report of a symposium.老年期的抑郁症与疾病:一场研讨会的报告
J Am Geriatr Soc. 1996 Feb;44(2):198-203. doi: 10.1111/j.1532-5415.1996.tb02440.x.
10
Sexual Dysfunction in Primary Care: An Exploratory Descriptive Analysis of Medical Record Diagnoses.初级保健中的性功能障碍:病历诊断的探索性描述性分析。
J Sex Med. 2017 Nov;14(11):1318-1326. doi: 10.1016/j.jsxm.2017.09.014.

引用本文的文献

1
Identifying Key Genes and Approved Medications Associated with Major Depressive Disorder Using Network Analysis and Systems Biology.使用网络分析和系统生物学识别与重度抑郁症相关的关键基因和获批药物。
Iran J Psychiatry. 2024 Oct;19(4):367-383. doi: 10.18502/ijps.v19i4.16550.
2
Prevalence and Influencing Factors of Severe Depression in Nurses During and After the COVID-19 Pandemic: A Large-Scale Multicenter Study.新冠疫情期间及之后护士中重度抑郁症的患病率及影响因素:一项大规模多中心研究
Depress Anxiety. 2024 Dec 20;2024:5727506. doi: 10.1155/da/5727506. eCollection 2024.
3
ICD-11 Prolonged Grief Disorder, Physical Health, and Somatic Problems: A Systematic Review.
《国际疾病分类第11版》持续性悲伤障碍、身体健康与躯体问题:一项系统综述
Clin Psychol Eur. 2025 Feb 28;7(1):e14351. doi: 10.32872/cpe.14351. eCollection 2025 Feb.
4
Mediating Effect of Emotional Symptoms on the Association Between Alexithymia and Substance Dependence in Patients with Substance Use Disorder: The Protective Role of Family Support and Self-Efficacy.情绪症状在物质使用障碍患者述情障碍与物质依赖关联中的中介作用:家庭支持和自我效能感的保护作用
Psychol Res Behav Manag. 2024 Nov 8;17:3863-3874. doi: 10.2147/PRBM.S478305. eCollection 2024.
5
LSDDEP2: study protocol for a randomised, double-dummy, triple-blind, active placebo-controlled, parallel groups trial of LSD microdosing in patients with major depressive disorder.LSDDEP2 研究方案:一项在重度抑郁症患者中进行 LSD 微量给药的随机、双盲、三盲、活性安慰剂对照、平行组试验的研究方案。
Trials. 2024 Aug 24;25(1):560. doi: 10.1186/s13063-024-08384-3.
6
Socioeconomic differences in limited lung function: a cross-sectional study of middle-aged and older adults in Germany.社会经济差异与肺功能受限:德国中老年人群的横断面研究。
Int J Equity Health. 2024 Jul 10;23(1):138. doi: 10.1186/s12939-024-02224-1.
7
Zuranolone for treatment of major depressive disorder: a systematic review and meta-analysis.用于治疗重度抑郁症的祖拉诺酮:一项系统评价和荟萃分析。
Front Neurosci. 2024 Apr 25;18:1361692. doi: 10.3389/fnins.2024.1361692. eCollection 2024.
8
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes.加拿大心境与焦虑治疗网络(CANMAT)2023 年成人重性抑郁障碍管理临床指南更新:加拿大心境与焦虑治疗网络(CANMAT)2023 年成人重性抑郁障碍管理临床指南更新
Can J Psychiatry. 2024 Sep;69(9):641-687. doi: 10.1177/07067437241245384. Epub 2024 May 6.
9
[Comorbidities in multiple sclerosis and their influence on the choice of treatment].[多发性硬化症的合并症及其对治疗选择的影响]
Rev Neurol. 2024 Mar 16;78(6):157-170. doi: 10.33588/rn.7806.2023277.
10
Neuropsychiatric Effects in Patients With Invasive Prolactinomas Treated With Cabergoline.使用卡麦角林治疗的侵袭性泌乳素瘤患者的神经精神影响。
Cureus. 2023 Jun 2;15(6):e39869. doi: 10.7759/cureus.39869. eCollection 2023 Jun.